{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:15:02Z","timestamp":1770884102717,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,3,21]],"date-time":"2009-03-21T00:00:00Z","timestamp":1237593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s10067-009-1165-4","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T06:18:08Z","timestamp":1237529888000},"page":"865-866","source":"Crossref","is-referenced-by-count":13,"title":["Systemic mastocytosis presenting as osteoporosis\u2014a case report"],"prefix":"10.1007","volume":"28","author":[{"given":"R.","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,21]]},"reference":[{"issue":"3","key":"1165_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.beha.2005.07.010","volume":"19","author":"A Pardanani","year":"2006","unstructured":"Pardanani A, Akin C, Valent P (2006) Pathogenesis, clinical features, and treatment advances in mastocytosis. Best Pract Res Clin Haematol 19(3):595\u2013615","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"1165_CR2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002920000439","volume":"22","author":"G Delling","year":"2001","unstructured":"Delling G, Ritzel H, Werner M (2001) Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis, A retrospective analysis of 158 cases. Pathologe 22(2):132\u2013140","journal-title":"Pathologe"},{"issue":"1","key":"1165_CR3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2006.03.004","volume":"36","author":"N Chiappetta","year":"2006","unstructured":"Chiappetta N, Gruber B (2006) The role of mast cells in osteoporosis. Semin Arthritis Rheum 36(1):32\u201336","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1165_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4652(199710)173:1<10::AID-JCP2>3.0.CO;2-M","volume":"173","author":"C Dobigny","year":"1997","unstructured":"Dobigny C, Saffar JL (1997 Oct) H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol 173(1):10\u201318","journal-title":"J Cell Physiol"},{"key":"1165_CR5","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","volume":"14","author":"S Verstovsek","year":"2008","unstructured":"Verstovsek S, Tefferi A, Cortes J et al (2008) Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res 14:3906\u20133915","journal-title":"Clin Cancer Res"},{"key":"1165_CR6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/ard.2004.029116","volume":"64","author":"AYN Lim","year":"2005","unstructured":"Lim AYN, Ostor AJK, Love S, Crisp AJ (2005) Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis 64:965\u2013966","journal-title":"Ann Rheum Dis"},{"key":"1165_CR7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/35.9.898","volume":"35","author":"T Lehman","year":"1996","unstructured":"Lehman T, Beyeler C (1996) Severe osteoporosis due to systemic mast cell disease: successful treatment with Interferon alpha 2B. Br J Rheumatol 35:898\u2013900","journal-title":"Br J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1165-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1165-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:35Z","timestamp":1559105495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1165-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,21]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1165-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,21]]}}}